 |
인쇄하기
취소
|
CellBiotech's drug for atopic therapy to complete clinical studies.
CellBiotech announced on Sept. 14 that a domestic clinical study on the new drug developed from a lactobacillus bacteria, a combined ATP lactobacillus, for the treatment of atopic skin diseases was successfully completed.
The study for its efficacy and safety via oral administration of the ATP combined lactobacillus preparation confirmed over 50% of improvement from atopic dermatitis.
The...
The study for its efficacy and safety via oral administration of the ATP combined lactobacillus preparation confirmed over 50% of improvement from atopic dermatitis.
The...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.